José Manuel Rojas Díaz is working on addressing the high mortality rate of cervical cancer in Mexican women by developing a novel technology called BiKE (bispecific killer cell engager). This technology is designed to target a specific tumour marker, recruiting and stimulating immune cells (NK cells) to enhance the antitumour response against cervical cancer cells, offering a promising therapeutic strategy for improving patient outcomes.

Further Activities to have a look at